Dr Reddy’s Laboratories Share Price Target 2024 to 2030: Can DRREDDY touch 8000 INR in 2024?

Dr. Reddy’s Laboratories Limited (NSE: DRREDDY) is a renowned pharmaceutical company that is engaged in the development and marketing of high-quality medicines both in India and globally. The company’s stock price is currently at Rs. 6,310, as of March 2024, with investors showing optimism towards its future growth prospects.

Dr. Reddy’s recent partnership announcement with Aster Pharmacy to market its products in the UAE and GCC indicates that the company is ready for further expansion in the years to come.

This article will explore the potential share price target of Dr. Reddy’s from 2024 to 2030 and provide an assessment of whether it could be a promising stock to invest in.

• Net profit rose by 10.6% to Rs 1,378.9 crore.
• Revenue reached Rs 7,214.8 crore, up 6.6% YoY.
• North America sales grew by 9% to Rs 3,350 crore.
• India sales increased by 5% YoY but declined by 1% QoQ.
• Russia revenue declined by 14% YoY but grew by 2% QoQ.
• EBITDA rose by 7.4% to Rs 2,210.7 crore, with a margin of 29.3%.
• Expenses increased, with SG&A up 12% YoY and R&D accounting for 7.7% of revenue.
• The company filed 38 DMFs globally and launched new products in India and North America. Overall, Dr. Reddy’s demonstrated resilience amidst challenges like price erosion and currency fluctuations, driven by new product launches and market share gains.

How to buy Dr Reddy’s Laboratories Shares?

You can buy Dr Reddy’s Laboratories shares from the following trading platforms:

➤ Zerodha

➤ Upstox

➤ Groww

➤ AngelOne

➤ ICICIDirect

Share Price Prediction of Dr. Reddy’s Laboratories: 2024, 2025 to 2030

Share Price Target 2024 of Dr Reddy’s Laboratories

In 2024, Dr. Reddy’s Laboratories is expected to witness fluctuations in its maximum and minimum prices throughout the year. The year will commence with a maximum price reaching approximately 6,380 rupees and a minimum price around 5,548 rupees in March, gradually fluctuating throughout the months. By December, as the year concludes, the company’s maximum price is anticipated to peak at around 6,972 rupees, with a minimum price of approximately 6,062 rupees.

Share Price Target 2025 of Dr Reddy’s Laboratories

Throughout 2025, Dr. Reddy’s Laboratories is forecasted to witness variations in its maximum and minimum prices. Starting with January, maximum prices are expected to hover around 6,979 rupees, with minimum prices at approximately 5,368 rupees. As the year progresses, both maximum and minimum prices are likely to fluctuate until December. By the end of December, maximum prices are projected to reach around 7,982 rupees, while minimum prices are anticipated to settle near 6,140 rupees.

Dr Reddy’s Laboratories Share Price Prediction 2026

Dr Reddy’s Laboratories Share Price Prediction 2027

Dr Reddy’s Laboratories Share Price Prediction 2028

Dr Reddy’s Laboratories Share Price Prediction 2029

Dr Reddy’s Laboratories Share Price Prediction 2030

In the span of 2030, Dr. Reddy’s Laboratories is poised to encounter a dynamic market landscape, reflecting in the oscillation of its maximum and minimum prices. As January unfolds, the maximum price is forecasted to orbit around 18,163 rupees, while the minimum price is expected to settle at approximately 13,972 rupees. Through the ensuing months, this trend of fluctuation is projected to persist, illustrating the inherent volatility within the market. By the culmination of December, the trajectory suggests a potential apex in maximum prices, reaching an estimated 21,709 rupees, with minimum prices exhibiting stability around 16,699 rupees, showcasing the company’s resilience amidst market dynamics.

Financial Condition of Dr. Reddy’s Laboratories: Last 5 years

Over the last five years, Dr. Reddy’s Laboratories has demonstrated a mixed but generally positive financial performance. The company’s sales have seen a steady upward trend, increasing from ₹15,448 crores in 2019 to ₹24,670 crores in 2023. Despite this growth, expenses have also risen, reaching ₹18,200 crores in 2023. Operating profit has shown fluctuations, with a notable increase to ₹6,470 crores in 2023, indicating a robust operational performance. The operating profit margin (OPM) increased from 21% in 2019 to 26% in 2023, showing improved efficiency in managing costs.

Other income has been on the rise, reaching ₹971 crores in 2023, while interest expenses remained relatively stable. Depreciation costs have increased but have been managed within a reasonable range. Profit before tax surged to ₹6,048 crores in 2023, a substantial increase from 2019. The company effectively reduced its tax rate to 25% in 2023, contributing to the growth in net profit, which reached ₹4,507 crores. Earnings per share (EPS) also exhibited remarkable growth, from ₹117.42 in 2019 to ₹270.66 in 2023.

Dr. Reddy’s Laboratories has consistently demonstrated its ability to adapt to changing market conditions and enhance its financial performance over the past five years, making it an attractive prospect for investors. The decreasing dividend payout percentage suggests that the company may be reinvesting more profits into its operations for future growth.

FAQS

Will the share price of Dr Reddy’s Laboratories increase in 2024?

It is anticipated that Dr Reddy’s Laboratories per share price will increase to ₹6,971.62 by the end of 2024.

What is the share price target 2025 of Dr Reddy’s Laboratories?

The share price target of Dr Reddy’s Laboratories for 2025 might be around ₹7,982.48.

What is the share price target 2030 of Dr Reddy’s Laboratories?

The per share price of Dr Reddy’s Laboratories might reach around ₹21,709.14 by the end of 2030.

Can Dr Reddy be classified as a multinational company?

Yes, Dr Reddy’s Laboratories is a pharmaceutical company headquartered in Hyderabad, India, with operations in multiple countries, making it a multinational corporation.

Also read:

• NMDC Share Price Target 2024 to 2030: Can NMDC touch 600 INR by 2030?
• Tanla Platforms Share Price Target 2024 to 2030: Can (NSE: TANLA) touch 800 INR in 2024?
• CMS Info Systems Share Price Target 2024 to 2030: Can it touch 1000 INR by 2030?

Conclusion

Dr. Reddy’s Laboratories emerges as a compelling investment opportunity in the pharmaceutical sector, with a promising trajectory for future growth. The company’s robust financial performance, highlighted by steady revenue growth, expanding profit margins, and strategic partnerships for international expansion, underscores its resilience and adaptability in navigating dynamic market conditions. With a strong foothold in both domestic and global markets, coupled with proactive measures to capitalize on emerging opportunities, Dr. Reddy’s Laboratories is well-positioned to deliver value to its shareholders in the years ahead. As investors continue to show optimism towards its future prospects, Dr. Reddy’s Laboratories stands out as a beacon of innovation and excellence in the pharmaceutical landscape.

Author: Neha BhardwajHello, I am Neha. I am currently pursuing B.Sc (Hons.) Computer Science from Hansraj College, University of Delhi. I am skilled in web content writing and my interest lies in the field of Data Analytics, Finance and Marketing.